|
2006E-0261: Patent Extension Application for EXJADE (deferasirox), U.S. Patent No. 6,465,504
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed Date
|
| Submitter Code
|
| Submitter
|
| FR Date
|
| FR Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
| APP1
|
| 06/19/2006
|
| 06/19/2006
|
| Private Industry
|
| Novartis
|
|
|
|
|
|
|
| Table of Contents
|
|
|
|
|
| Signature:
|
| Oona A. Jackson
|
|
|
|
|
| LET1
|
| 06/19/2006
|
| 06/19/2006
|
| Federal Government
|
| U.S. Patent and Trademark Office
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Kery A. Fries
|
|
|
|
|
|
|
|
| LET2
|
| 07/28/2006
|
| 07/28/2006
|
| Federal Government
|
| FDA/CDER to U.S. Patent and Tradmark Office
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Jane A. Axelrad
|
|
|
|
|
|
|
|
| LET3
|
| 01/16/2007
|
| 01/16/2007
|
| Federal Government
|
| U.S. Patent and Trademark Office to FDA/CDER (HFD-7)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
|
|
|
|
|
|
| Signature:
|
| Kathleen Kahler Fonda
|
|
|
|
|
|
|
|
|
|
Top | Up
Page last updated:
February 23, 2007
|
